New pill aims to help seniors regain strength and mobility

NCT ID NCT07390552

First seen Feb 05, 2026 · Last updated May 11, 2026 · Updated 21 times

Summary

This study tests an experimental oral medication, PLH-2301, in 168 adults aged 65 and older who have sarcopenia (age-related muscle loss). Participants will take either a placebo or one of three doses of the drug daily for 12 weeks. The main goal is to see if the drug improves physical function, such as walking speed and balance, compared to a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA IN ELDERLY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Korea University Anam Hospital

    Seoul, Seoul, 02841, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Korea University Guro Hospital

    Seoul, Seoul, 08308, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Seoul St. Mary's Hospital

    Seoul, Seoul, 06591, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.